OpportunityTitle: Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trials Optional
AdditionalInformationOnEligibility: Duke University
Description: The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a Cooperative Agreement to the Duke University&#8217;s Duke Clinical Research Institute (DCRI) to support the Clinical Trials Transformation Initiative (CTTI).
GrantorContactEmailDescription: terrin.brown@fda.hhs.gov
GrantorContactText: Terrin Brown &lt;br/&gt;Grantor